{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:14:46Z","timestamp":1759961686596},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T00:00:00Z","timestamp":1498608000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"This work was supported by public fund (\u201cSapienza\u201d Rome University, Bando Ricerca Scientifica, 2015)."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s12020-017-1351-0","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T09:44:41Z","timestamp":1498643081000},"page":"338-343","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Mineral metabolism abnormalities in patients with prostate cancer: a systematic case controlled study"],"prefix":"10.1007","volume":"59","author":[{"given":"Francesco","family":"Minisola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Colangelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirella","family":"Cilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Sciarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Von Heland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Nieddu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Anastasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Pascone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Fassino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Diacinti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Minisola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,28]]},"reference":[{"key":"1351_CR1","unstructured":"World Cancer Research Fund International (2016), http:\/\/www.wcrf.org. Accessed 26 Dec 2016"},{"issue":"1","key":"1351_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bone.2004.09.017","volume":"36","author":"RC Pelger","year":"2005","unstructured":"R.C. Pelger, A.N.G.A. Lycklama, S.E. Papapoulos, N.A. Hamdy, Severe hypophosphatemic osteomalacia in hormone-refractory prostate cancer metastatic to the skeleton: natural history and pitfalls in management. Bone 36(1), 1\u20135 (2005). doi:\n                        10.1016\/j.bone.2004.09.017","journal-title":"Bone"},{"issue":"5","key":"1351_CR3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1464-410X.1987.tb05011.x","volume":"60","author":"S Minisola","year":"1987","unstructured":"S. Minisola, G. Perugia, A. Scarda, L. Scarnecchia, D. Tuzzolo, W. Rossi, G. Mazzuoli, Biochemical picture accompanying sclerotic bone metastases of prostatic origin. Br. J. Urol. 60(5), 443\u2013446 (1987)","journal-title":"Br. J. Urol."},{"issue":"6","key":"1351_CR4","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1053\/j.ajkd.2007.07.031","volume":"50","author":"CL Cotant","year":"2007","unstructured":"C.L. Cotant, P.S. Rao, Elevated fibroblast growth factor 23 in a patient with metastatic prostate cancer and hypophosphatemia. Am. J. Kidney Dis. 50(6), 1033\u20131036 (2007). doi:\n                        10.1053\/j.ajkd.2007.07.031","journal-title":"Am. J. Kidney Dis."},{"issue":"9","key":"1351_CR5","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s00520-012-1474-z","volume":"20","author":"MP Mak","year":"2012","unstructured":"M.P. Mak, V.T. da Costa e Silva, R.M. Martin, A.M. Lerario, L. Yu, P.M. Hoff, G. de Castro Jr., Advanced prostate cancer as a cause of oncogenic osteomalacia: an underdiagnosed condition. Supp. Care Cancer 20(9), 2195\u20132197 (2012). doi:\n                        10.1007\/s00520-012-1474-z","journal-title":"Supp. Care Cancer"},{"key":"1351_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-physiol-030212-183727","volume":"75","author":"MC Hu","year":"2013","unstructured":"M.C. Hu, K. Shiizaki, M. Kuro-o, O.W. Moe, Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu. Rev. Physiol. 75, 503\u2013533 (2013). doi:\n                        10.1146\/annurev-physiol-030212-183727","journal-title":"Annu. Rev. Physiol."},{"issue":"9","key":"1351_CR7","first-page":"1478","volume":"41","author":"V Carnevale","year":"2000","unstructured":"V. Carnevale, F. Dicembrino, V. Frusciante, I. Chiodini, S. Minisola, A. Scillitani, Different patterns of global and regional skeletal uptake of 99mTc-methylene diphosphonate with age: relevance to the pathogenesis of bone loss. J. Nucl. Med. 41(9), 1478\u20131483 (2000)","journal-title":"J. Nucl. Med."},{"issue":"5","key":"1351_CR8","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1464-410X.2012.11611.x","volume":"111","author":"PM Pierorazio","year":"2013","unstructured":"P.M. Pierorazio, P.C. Walsh, A.W. Partin, J.I. Epstein, Prognostic Gleason grade grouping: data based on the modified Gleason scoring system. BJU Int. 111(5), 753\u2013760 (2013). doi:\n                        10.1111\/j.1464-410X.2012.11611.x","journal-title":"BJU Int."},{"issue":"1","key":"1351_CR9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"D.W. Cockcroft, M.H. Gault, Prediction of creatinine clearance from serum creatinine. Nephron 16(1), 31\u201341 (1976)","journal-title":"Nephron"},{"issue":"7929","key":"1351_CR10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(75)92736-1","volume":"2","author":"RJ Walton","year":"1975","unstructured":"R.J. Walton, O.L. Bijvoet, Nomogram for derivation of renal threshold phosphate concentration. Lancet 2(7929), 309\u2013310 (1975)","journal-title":"Lancet"},{"issue":"10","key":"1351_CR11","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1210\/jc.2010-0502","volume":"95","author":"C Cipriani","year":"2010","unstructured":"C. Cipriani, E. Romagnoli, A. Scillitani, I. Chiodini, R. Clerico, V. Carnevale, M.L. Mascia, C. Battista, R. Viti, M. Pileri, C. Eller-Vainicher, S. Minisola, Effect of a single oral dose of 600,000 IU of cholecalciferol on serum calciotropic hormones in young subjects with vitamin D deficiency: a prospective intervention study. J. Clin. Endocrinol. Metab. 95(10), 4771\u20134777 (2010). doi:\n                        10.1210\/jc.2010-0502","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1-2","key":"1351_CR12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/biomet\/34.1-2.123","volume":"34","author":"GA Barnard","year":"1947","unstructured":"G.A. Barnard, Significance tests for 2 X 2 tables. Biometrika 34(1\u20132), 123\u2013138 (1947)","journal-title":"Biometrika"},{"key":"1351_CR13","doi-asserted-by":"publisher","first-page":"h2723","DOI":"10.1136\/bmj.h2723","volume":"350","author":"S Minisola","year":"2015","unstructured":"S. Minisola, J. Pepe, S. Piemonte, C. Cipriani, The diagnosis and management of hypercalcaemia. BMJ 350, h2723 (2015). doi:\n                        10.1136\/bmj.h2723","journal-title":"BMJ"},{"issue":"4","key":"1351_CR14","doi-asserted-by":"publisher","first-page":"R59","DOI":"10.1530\/EJE-13-0435","volume":"169","author":"E Romagnoli","year":"2013","unstructured":"E. Romagnoli, J. Pepe, S. Piemonte, C. Cipriani, S. Minisola, Management of endocrine disease: value and limitations of assessing vitamin D nutritional status and advised levels of vitamin D supplementation. Eur. J. Endocrinol. 169(4), R59\u201369 (2013). doi:\n                        10.1530\/EJE-13-0435","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"1351_CR15","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S2213-8587(16)00076-0","volume":"4","author":"S Minisola","year":"2016","unstructured":"S. Minisola, J. Pepe, A. Scillitani, C. Cipriani, Explaining geographical variation in the presentation of primary hyperparathyroidism. Lancet Diabetes Endocrinol. 4(8), 641\u2013643 (2016). doi:\n                        10.1016\/S2213-8587(16)00076-0","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1351_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-3-642-21892-7_2","volume":"192","author":"D Santini","year":"2012","unstructured":"D. Santini, F. Pantano, B. Vincenzi, G. Tonini, F. Bertoldo, The role of bone microenvironment, vitamin D and calcium. Recent Results Cancer Res. 192, 33\u201364 (2012). doi:\n                        10.1007\/978-3-642-21892-7_2","journal-title":"Recent Results Cancer Res."},{"issue":"3","key":"1351_CR17","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1158\/1055-9965.EPI-07-2747","volume":"17","author":"GG Schwartz","year":"2008","unstructured":"G.G. Schwartz, Prostate cancer, serum parathyroid hormone, and the progression of skeletal metastases. Cancer Epidemiol. Prevention Biomarkers 17(3), 478\u2013483 (2008). doi:\n                        10.1158\/1055-9965.EPI-07-2747","journal-title":"Cancer Epidemiol. Prevention Biomarkers"},{"issue":"9","key":"1351_CR18","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/jnci\/djs189","volume":"104","author":"IM Shui","year":"2012","unstructured":"I.M. Shui, L.A. Mucci, P. Kraft, R.M. Tamimi, S. Lindstrom, K.L. Penney, K. Nimptsch, B.W. Hollis, N. Dupre, E.A. Platz, M.J. Stampfer, E. Giovannucci, Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study. J. Natl Cancer Inst. 104(9), 690\u2013699 (2012). doi:\n                        10.1093\/jnci\/djs189","journal-title":"J. Natl Cancer Inst."},{"issue":"12","key":"1351_CR19","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1002\/cncr.29320","volume":"121","author":"IM Shui","year":"2015","unstructured":"I.M. Shui, A.M. Mondul, S. Lindstrom, K.K. Tsilidis, R.C. Travis, T. Gerke, D. Albanes, L.A. Mucci, E. Giovannucci, P. Kraft, Breast, prostate cancer cohort consortium, G.: circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the national cancer institute breast and prostate cancer cohort consortium. Cancer 121(12), 1949\u20131956 (2015). doi:\n                        10.1002\/cncr.29320","journal-title":"Cancer"},{"issue":"11","key":"1351_CR20","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s40618-014-0158-6","volume":"37","author":"A Bian","year":"2014","unstructured":"A. Bian, C. Xing, M.C. Hu, Alpha Klotho and phosphate homeostasis. J. Endocrinol. Invest. 37(11), 1121\u20131126 (2014). doi:\n                        10.1007\/s40618-014-0158-6","journal-title":"J. Endocrinol. Invest."},{"issue":"19","key":"1351_CR21","doi-asserted-by":"publisher","first-page":"17291","DOI":"10.18632\/oncotarget.4174","volume":"6","author":"S Feng","year":"2015","unstructured":"S. Feng, J. Wang, Y. Zhang, C.J. Creighton, M. Ittmann, FGF23 promotes prostate cancer progression. Oncotarget 6(19), 17291\u201317301 (2015). doi:\n                        10.18632\/oncotarget.4174","journal-title":"Oncotarget"},{"issue":"2","key":"1351_CR22","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/bju.12396","volume":"114","author":"HJ Kim","year":"2014","unstructured":"H.J. Kim, K.H. Kim, J. Lee, J.J. Oh, H.S. Cheong, E.L. Wong, B.S. Yang, S.S. Byun, S.C. Myung, Single nucleotide polymorphisms in fibroblast growth factor 23 gene, FGF23, are associated with prostate cancer risk. BJU Int. 114(2), 303\u2013310 (2014). doi:\n                        10.1111\/bju.12396","journal-title":"BJU Int."},{"issue":"2","key":"1351_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMoa041943","volume":"352","author":"VB Shahinian","year":"2005","unstructured":"V.B. Shahinian, Y.F. Kuo, J.L. Freeman, J.S. Goodwin, Risk of fracture after androgen deprivation for prostate cancer. N. Engl. J. Med. 352(2), 154\u2013164 (2005). doi:\n                        10.1056\/NEJMoa041943","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"1351_CR24","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.mehy.2014.08.005","volume":"83","author":"EK Lee","year":"2014","unstructured":"E.K. Lee, M.C. Martinez, K. Blakely, K.D. Santos, V.C. Hoang, A. Chow, U. Emmenegger, FGF23: mediator of poor prognosis in a sizeable subgroup of patients with castration-resistant prostate cancer presenting with severe hypophosphatemia? Med. Hypotheses 83(4), 482\u2013487 (2014). doi:\n                        10.1016\/j.mehy.2014.08.005","journal-title":"Med. Hypotheses"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-017-1351-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1351-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1351-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T10:31:39Z","timestamp":1517394699000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-017-1351-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,28]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["1351"],"URL":"https:\/\/doi.org\/10.1007\/s12020-017-1351-0","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,28]]}}}